Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells
Abstract Background Despite a long history of investigation and sustained efforts in clinical testing, the number of market authorisations for mesenchymal stromal cell (MSC) therapies remains limited, with none approved by the United States Food and Drug Administration. Several barriers are impeding...
Main Authors: | Joan C. Fitzgerald, Georgina Shaw, J. Mary Murphy, Frank Barry |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-023-03589-w |
Similar Items
-
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
The potency of mesenchymal stem/stromal cells: does donor sex matter?
by: Ghada Maged, et al.
Published: (2024-04-01) -
The Human Placental Amniotic Membrane Mesenchymal-Stromal-Cell-Derived Conditioned Medium Inhibits Growth and Promotes Apoptosis of Human Cholangiocarcinoma Cells In Vitro and In Vivo by Suppressing IL-6/JAK2/STAT3 Signaling
by: Tanachapa Jantalika, et al.
Published: (2023-12-01) -
Regenerative potential of mesenchymal stromal cells in wound healing: unveiling the influence of normoxic and hypoxic environments
by: Mohamad Mahjoor, et al.
Published: (2023-10-01) -
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
by: Dragan Primorac, et al.
Published: (2021-09-01)